The interleukin-2 receptor in lesions and serum of bullous pemphigoid. 1992

D Zillikens, and A Ambach, and M Schuessler, and R Dummer, and A A Hartmann, and G Burg
Department of Dermatology, University of Würzburg, Federal Republic of Germany.

The interleukin-2 receptor (IL-2R) is mainly expressed on activated T cells. Depending on its rate of synthesis, a portion is released from the cell surface as soluble IL-2R (sIL-2R). Since the role of mononuclear cells in the pathology of bullous pemphigoid (BP) is not well understood, we determined the sIL-2R in both blister fluid and serum of 15 BP patients with generalized disease before initiating systemic treatment. In addition, we obtained both lesional and perilesional skin biopsies and examined the mononuclear infiltrate with a panel of monoclonal antibodies. In BP blisters, sIL-2R levels were significantly increased (2070 +/- 350 U/ml), (+/- SEM) compared with serum samples taken at the time of blister puncture (1340 +/- 290 U/ml). In six patients with blisters due to second-degree burns or friction and in five suction blister volunteers, sIL-2R levels were normal in both blisters and serum. In BP, elevated serum levels decreased to normal during therapy, correlating with disease activity. The immunohistology showed that 30% of mononuclear cells in the dermal infiltrate of lesional skin expressed the IL-2R, whereas only 15% were positive in perilesional skin. IL-2R-positive cells are the most likely source of the shed receptor in BP blisters. Our results indicate the presence of activated T cells in lesions and peripheral blood of BP and thus underline the importance of cell-mediated immune mechanisms in the pathology of this disease.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D010391 Pemphigoid, Bullous A chronic and relatively benign subepidermal blistering disease usually of the elderly and without histopathologic acantholysis. Pemphigoid,Bullous Pemphigoid,Pemphigoids
D001768 Blister Visible accumulations of fluid within or beneath the epidermis. Bulla,Vesication,Bleb,Bullae,Bullous Lesion,Blebs,Blisters,Bullous Lesions,Lesion, Bullous,Lesions, Bullous,Vesications
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015375 Receptors, Interleukin-2 Receptors present on activated T-LYMPHOCYTES and B-LYMPHOCYTES that are specific for INTERLEUKIN-2 and play an important role in LYMPHOCYTE ACTIVATION. They are heterotrimeric proteins consisting of the INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT, the INTERLEUKIN-2 RECEPTOR BETA SUBUNIT, and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN. IL-2 Receptors,Interleukin-2 Receptor,Interleukin-2 Receptors,Receptors, IL-2,Receptors, T-Cell Growth Factor,T-Cell Growth Factor Receptors,IL-2 Receptor,IL2 Receptor,IL2 Receptors,Interleukin 2 Receptor,Receptor, TCGF,T-Cell Growth Factor Receptor,TCGF Receptor,TCGF Receptors,IL 2 Receptor,IL 2 Receptors,Interleukin 2 Receptors,Receptor, IL-2,Receptor, IL2,Receptor, Interleukin 2,Receptor, Interleukin-2,Receptors, IL 2,Receptors, IL2,Receptors, Interleukin 2,Receptors, T Cell Growth Factor,Receptors, TCGF,T Cell Growth Factor Receptor,T Cell Growth Factor Receptors

Related Publications

D Zillikens, and A Ambach, and M Schuessler, and R Dummer, and A A Hartmann, and G Burg
January 1990, Archives of dermatological research,
D Zillikens, and A Ambach, and M Schuessler, and R Dummer, and A A Hartmann, and G Burg
January 1984, Archives of dermatological research,
D Zillikens, and A Ambach, and M Schuessler, and R Dummer, and A A Hartmann, and G Burg
January 2023, Frontiers in immunology,
D Zillikens, and A Ambach, and M Schuessler, and R Dummer, and A A Hartmann, and G Burg
June 1969, Archives of dermatology,
D Zillikens, and A Ambach, and M Schuessler, and R Dummer, and A A Hartmann, and G Burg
April 1989, Journal of the American Academy of Dermatology,
D Zillikens, and A Ambach, and M Schuessler, and R Dummer, and A A Hartmann, and G Burg
January 1973, Journal of oral medicine,
D Zillikens, and A Ambach, and M Schuessler, and R Dummer, and A A Hartmann, and G Burg
January 1971, Polish medical journal,
D Zillikens, and A Ambach, and M Schuessler, and R Dummer, and A A Hartmann, and G Burg
April 1984, The Journal of investigative dermatology,
D Zillikens, and A Ambach, and M Schuessler, and R Dummer, and A A Hartmann, and G Burg
October 2001, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
D Zillikens, and A Ambach, and M Schuessler, and R Dummer, and A A Hartmann, and G Burg
February 2005, The British journal of dermatology,
Copied contents to your clipboard!